Bonne Biesma
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 39
- Lung Cancer Diagnosis and Treatment 15
- Occupational and environmental lung diseases 5
- Oncology 39
- Lung Cancer Research Studies 26
- Neutropenia and Cancer Infections 11
- Co-authors
- Egbert Frederik Smit (22 shared papers)Joachim von Pawel (5 shared papers)Johan Vansteenkiste (4 shared papers)Giorgio V. Scagliotti (4 shared papers)Filippo de Marinis (3 shared papers)Keunchil Park (3 shared papers)Christian Manegold (3 shared papers)Ulrich Gatzemeier (3 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Lung Cancer (11 papers)Annals of Oncology (10 papers)British Journal of Cancer (6 papers)Journal of Thoracic Oncology (6 papers)
- Partner nations
- NetherlandsGermanyBelgium
In The Last Decade
Bonne Biesma
81 papers receiving 7.2k citations
Bonne Biesma's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 4.0k
- Cancer Research 572
- Hematology 266
- Otorhinolaryngology 92
Countries citing papers authored by Bonne Biesma
This map shows the geographic impact of Bonne Biesma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonne Biesma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonne Biesma more than expected).
Fields of papers citing papers by Bonne Biesma
This network shows the impact of papers produced by Bonne Biesma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonne Biesma. The network helps show where Bonne Biesma may publish in the future.
Co-authors
The 25 scholars most cited alongside Bonne Biesma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer Hit paper breakdown → | 2008 | 2714 |
| 2 | Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer Hit paper breakdown → | 2007 | 542 |
| 3 | 2010 | 355 | |
| 4 | PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2016 | 344 |
| 5 | 2003 | 303 | |
| 6 | 2005 | 213 | |
| 7 | 2012 | 208 | |
| 8 | 2006 | 167 | |
| 9 | 1998 | 156 | |
| 10 | 2005 | 149 | |
| 11 | 2009 | 122 | |
| 12 | 2009 | 100 | |
| 13 | 1999 | 99 | |
| 14 | 2011 | 93 | |
| 15 | 2001 | 86 | |
| 16 | 1994 | 84 | |
| 17 | 2002 | 84 | |
| 18 | 2011 | 84 | |
| 19 | A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma. | 1991 | 83 |
| 20 | 1991 | 82 |
About Bonne Biesma
Bonne Biesma is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Hematology and Neurology, having authored 84 papers that have together received 7.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (26 papers), Lung Cancer Diagnosis and Treatment (15 papers), Neutropenia and Cancer Infections (11 papers), Neuroendocrine Tumor Research Advances (7 papers), Occupational and environmental lung diseases (5 papers), Cancer therapeutics and mechanisms (4 papers) and Neuroblastoma Research and Treatments (3 papers). The work is most often cited by research in Oncology (3.4k citations), Pulmonary and Respiratory Medicine (4.0k citations), Cancer Research (572 citations), Hematology (266 citations) and Otorhinolaryngology (92 citations). Bonne Biesma has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include Egbert Frederik Smit, Joachim von Pawel, Johan Vansteenkiste, Giorgio V. Scagliotti, Filippo de Marinis, Keunchil Park, Christian Manegold, Ulrich Gatzemeier, Piotr Serwatowski and Purvish Mahendra Parikh. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, British Journal of Cancer and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.